EPNEstevão Portela NunesMD, PhDVideoHIVSalvador HIV Clinical Forum 2022Role of PIs on Current ART - Estevão Portela Nunes, MD, PhDView Video
LESLuis E. Soto-RamírezMDVideoHIVSalvador HIV Clinical Forum 2022Role of Nukes and Non-nukes in Current ART - Luis E. Soto-Ramírez, MDView Video
GMGustavo MagalhãesMD, PhDVideoHIVSalvador HIV Clinical Forum 2022Clinical Case (focused on prevention) - Gustavo Magalhães, MD, PhDView Video
AKAlícia KrügerPharmD, MPHVideoHIVSalvador HIV Clinical Forum 2022Community Perspective on Therapeutic PrEP Options - Alícia Krüger, PharmD, MPHView Video
EKEsper KallasMD, PhDVideoHIVSalvador HIV Clinical Forum 2022PrEP On-Demand vs Conventional - Esper Kallas, MD, PhDView Video
BGBeatriz GrinsztejnMD, PhDVideoHIVSalvador HIV Clinical Forum 2022Update on Therapeutic Options for HIV Prevention - Beatriz Grinsztejn, MD, PhDView Video
TVTânia VergaraMD, PhDVideoHIVSalvador HIV Clinical Forum 2022Choosing the Best Regimen For Older Patients With Comorbidities - Tânia Vergara, MD, PhDView Video
EKEsper KallasMD, PhDVideoHIVSalvador HIV Clinical Forum 2022Polypharmacy and ART Choice - Esper Kallas, MD, PhDView Video
MGMonica GandhiMD, MPHVideoHIVSalvador HIV Clinical Forum 2022Is Resistance a Concern When Starting ART? - Monica Gandhi, MD, MPHView Video
ESEduardo SprinzMDVideoHIVSalvador HIV Clinical Forum 2022International and Local Guidelines - Focus on Patients' Needs? - Eduardo Sprinz, MDView Video
SWSharon WalmsleyCM, MD, FRCPCVideoHIVGCC HIV Clinical Forum 2022Long-Acting Therapeutic Options for HIV Treatment and Prevention: A Review of Clinical Data - Sharon Walmsley, C.M. MD, FRCPCView Video
AAAhmad AlharbiMDVideoHIVGCC HIV Clinical Forum 2022Treatment Optimalization in Suppressed PLWH - Is 2DR an Option? - Ahmad Alharbi, MDView Video
